EDGAR Filing Documents for 0001724843-17-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001724843-17-000001

Filing Date

2017-12-13

Accepted

2017-12-13 09:42:55

Documents

Effectiveness Date

2017-12-13

Items

Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	7023
	Complete submission text file	0001724843-17-000001.txt		8167

Mailing Address 100 NORTH QUEEN STREET, FL3 LANCASTER PA 17603

Business Address 100 NORTH QUEEN STREET, FL3 LANCASTER PA 17603 717-405-1011

Aspire Ventures Precision Medicine Fund, LLC (Filer) CIK: 0001724843 (see all company filings)